Munafa Stock Market Course + Intraday & FNO calls 
EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising
EMCURE NEWS reasons for why stock price of Emcure Pharmaceuticals L is falling or rising
EMCURE Emcure Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Emcure Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Emcure Pharmaceuticals EMCURE at this time. Stock is rising and might rise more.
It appears as if Emcure Pharmaceuticals EMCURE gave a large move recently.
Stock of Emcure Pharmaceuticals (EMCURE) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Emcure Pharmaceuticals is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 1931.5, for a target of 1882.9 or 1842.34
EMCURE Emcure Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Update on completion of acquisition of shares of Gennova Biopharmaceuticals - NEWS as on 2026-07-23
ICMR licenses cancer, vaccine technologies to Emcure, Biological E The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and infectious disease protection. One drug candidate targets precancerous cervical cells, offering a safer treatment o - NEWS as on 2026-07-22 indiatimes.com
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company. - NEWS as on 2026-07-21
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 20, 2026, titled "Emcure to Expand the Use of PoviztraŽ for MASH Indication Following CDSCO Approval". - NEWS as on 2026-07-20
Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatment Emcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treating metabolic dysfunction-associated steatohepatitis in adults. Poviztra contains innovator semaglutide manufactured i - NEWS as on 2026-07-20 indiatimes.com
Company Announcement - NEWS as on 2026-07-16
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 13, 2026, titled "Press Release titled Emcure Consolidates Gennova Ownership; Sharpens Focus on Biologics; Samit Mehta Leads the Next Phase of Growth ". - NEWS as on 2026-07-14
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition - NEWS as on 2026-07-13
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Sale or disposal - NEWS as on 2026-07-13
Company Announcement Revised intimation of Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026 with correct enclosure. - NEWS as on 2026-07-08
Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 - NEWS as on 2026-07-08
More announcements and NEWS
EMCURE Emcure Pharmaceuticals L current price & indicator signals
Recent prices of EMCURE Emcure Pharmaceuticals L are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 27 Mon Jul 2026 | 1924.80 | 1882.10 to 1938.60 | 2.33% | 1.86 times |
| 24 Fri Jul 2026 | 1881.00 | 1855.40 to 1892.00 | 0.62% | 0.43 times |
| 23 Thu Jul 2026 | 1869.50 | 1864.20 to 1928.10 | -1.04% | 0.75 times |
| 22 Wed Jul 2026 | 1889.20 | 1877.00 to 1936.10 | -1.83% | 0.81 times |
| 21 Tue Jul 2026 | 1924.50 | 1874.00 to 1940.00 | 3.4% | 1.58 times |
| 20 Mon Jul 2026 | 1861.20 | 1776.50 to 1870.80 | 4.37% | 1.43 times |
| 17 Fri Jul 2026 | 1783.20 | 1751.00 to 1814.00 | -1.08% | 1.76 times |
| 16 Thu Jul 2026 | 1802.70 | 1780.10 to 1817.90 | 0.69% | 0.89 times |
| 15 Wed Jul 2026 | 1790.30 | 1785.50 to 1822.00 | -1.09% | 0.7 times |
| 14 Tue Jul 2026 | 1810.10 | 1786.10 to 1840.00 | 0.94% | 1.01 times |
| 13 Mon Jul 2026 | 1793.30 | 1785.50 to 1839.00 | -1.16% | 0.64 times |
| 10 Fri Jul 2026 | 1814.40 | 1801.80 to 1834.90 | 0.27% | 0.55 times |
Videos related to: EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
